PROFFERED PAPERS
Monday, March 9   —  1:00 PM   —  CC BR A


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...




Section C - GYNECOLOGIC
Chaired by: Russell Vang and Anais Malpica



TimeTitle and AuthorsItinerary
Planner
1:00 Is There an Association between the Micropapillary/Cribriform Pattern in Ovarian Serous Tumors of Low Malignant Potential and Microinvasion? (1069)
AA Roma, MT Deavers, A Malpica, EG Silva - Washington University in St Louis, St Louis, MO; M.D. Anderson Cancer Center, Houston, TX
Add
1:15 Decreased Copy Number in Chr1p36 and 9p21 May Be the Key Molecular Events in the Transformation of Ovarian Serous Borderline Tumors to Low Grade Serous Carcinoma (1016)
KT Kuo, RJ Kurman, TL Mao, TL Wang, IM Shih - National Taiwan University Hospital, Taipei, Taiwan; Johns Hopkins Medical Institutions, Baltimore, MD
Add
1:30 Epigenetic and Genetic Alterations in Low Grade Papillary Serous Carcinoma of the Ovary (931)
FA Shahin, X Ji, P Hui, F Abudul-Karim, W Liu, B Yang - Cleveland Clinic, Cleveland, OH; Yale University, CT; Case Western Reserve University, Cleveland, OH
Add
1:45 The Morphologic Spectrum of Immunohistochemically Characterized Clear Cell Carcinoma of the Ovary: A Study of 83 Cases (961)
D DeLair, R Soslow, B Gilks, A Macias, E Oliva - Memorial Sloan Kettering Cancer Center, New York, NY; Massachussets General Hospital, Boston, MA; Vancouver General Hospital, Vancouver, BC, Canada
Add
2:00 Ovarian Endometrioid and Clear Cell Carcinoma Arise Via Different Precursor Lesions and Have Better Prognosis When Associated with Endometriosis (958)
J Cuff, TA Longacre - Stanford University, Stanford, CA
Add
2:15 Clinicopathologic Analysis of Ovarian Clear Cell Carcinoma: Comparison of Cases with and without Adenofibromatous Components and Implications for Pathogenesis (1105)
C Zhao, R Barner, R Kurman, M Stamatakos, R Vang - Magee-Womens Hospital of UPMC, Pittsburgh, PA; Armed Forces Institute of Pathology, Washington, DC; Johns Hopkins Hospital, Baltimore, MD
Add
2:30 Frequent Glypican-3 Overexpression in Ovarian Clear Cell Adenocarcinoma (1030)
D Maeda, S Ota, Y Takazawa, H Aburatani, S Nakagawa, M Fukayama - Fuculty of Medicine, the University of Tokyo, Tokyo, Japan; Research Center for Advanced Science and Technology, the University of Tokyo, Tokyo, Japan; Faculty of Medicine, the University of Tokyo, Tokyo, Japan
Add
2:45 Refining the Criteria for Adjuvant Therapy: Histological Cell Type Is a Significant Prognostic Indicator in Low Stage Ovarian Carcinoma (1008)
M Kobel, J Santos, SE Kalloger, DG Huntsman, CB Gilks, K Swenerton - University of British Columbia and British Columbia Cancer Agency, Vancouver, BC, Canada
Add
3:00 RECESS, EXHIBITS, POSTER SESSION II  
4:30 NATHAN KAUFMAN TIMELY TOPICS LECTURE
Todd R. Golub, M.D.
Molecular Classification of Tumors
Hynes Convention Center Auditorium
Add